A survey of Scripps Health clinicians reveals that specialty and personal risk assessment of side effects drive the chronic cough treatment gap.

Biologic therapy during pregnancy was not associated with adverse outcomes for most patients in a retrospective study presented at AAAAI 2026.

Patients with hereditary angioedema report significant unmet needs, including high costs and insurance barriers, according to data from AAAAI 2026.

Novo Nordisk announced Tuesday that it will cut US list prices of Ozempic and Wegovy by up to 50% starting next year. The lower prices will take effect January 1, 2027, the same time that reduced ...

A retrospective cohort study of 210,000 pediatric patients showed ICS therapy did not elevate the risk for pediatric fractures.

Mepolizumab reduces moderate to severe COPD exacerbations in patients with varying blood eosinophil counts and type 2 inflammation.

Findings showed the ORR was 76% (95% CI, 65-85), with 11% achieving complete response and 65% achieving partial response. The Food and Drug Administration has granted accelerated approval to Hernexeos ...

HealthDay News — A measles outbreak at a private college in southwest Florida is raising new concerns about how quickly the ...

Phase 3 trial results demonstrate the superiority of long-acting injectable cabotegravir + rilpivirine over daily oral ...

The data suggest significant challenges in maintaining long-term disease control with advanced systemic therapies for atopic dermatitis.

A systematic review shows second generation antihistamines appear to be more effective and less sedating for patients managing chronic urticaria.

New data reveal that episodic lack of disease control in chronic spontaneous urticaria is linked to increased hospitalizations and outpatient visits.